Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat

Archives of Ophthalmology

Volumn 114, Issue 10, 1996, Pages 1210-1217

  Dorey, C Kathleen ^a,d   Aouididi, Samir ^a,c   Reynaud, Xavier ^b   Dvorak, Harold F ^a   Brown, Lawrence F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c HÔPITAL CHARLES NICOLLE   (France)

^d SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; HYPOXIA; IN SITU HYBRIDIZATION; MUELLER CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGENATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; RETINA AMACRINE CELL;

EID: 0029836760     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140410008     Document Type: Article

References (60)

1. Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to problem of retrolental fibroplasia. Br J Ophthalmol. 1954;38:397-432.
2. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc U K. 1949;68:137-180.
3. Virdi PS, Hayreh SS. Ocular neovascularization with retinal vascular occlusion, I: association with experimental retinal vein occlusion. Arch Ophthalmol. 1982; 100:331-341.
4. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology. 1990;97:1321-1328.
5. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
6. Miller H, Miller B, Ishibashi T, Ryan SJ. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci. 1990;31:899-908.
7. Phelps DL, Rosenbaum AL. Vitamin E in kitten oxygen-induced retinopathy, II: blockage of vitreal neovascularization. Arch Ophthalmol. 1979;97:1522-1526.
8. Patz A. Clinical and experimental studies on retinal neovascularization. Am J Ophthalmol. 1982;74:715-743.
9. Flower RW, McLeod DS, Lutty GA, Goldberg B, Wajer SD. Postnatal retinal vascular development of the puppy. Invest Ophthalmol Vis Sci. 1985;27:346-355.
10. Ricci B. Oxygen-induced retinopathy in the rat model. Doc Ophthalmol. 1990; 254:186-189.
11. Ventresca MR, Gonder JR, Tanswell AK. Oxygen-induced proliferative retinopathy in the newborn rat. Can J Ophthalmol. 1990;25:186-189.
12. Reynaud X, Dorey CK. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci. 1994;35:3169-3177.
13. Penn JS, Tolman BL, Lowery L. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993;34: 575-585.
14. Ernest JT, Goldstick TK. Retinal oxygen tension and oxygen reactivity in retinopathy of prematurity in kittens. Invest Ophthalmol Vis Sci. 1984;25:1129-1134.
15. Reynaud X, Hirose T, Dorey CK. Intermittent hypoxia stimulates neovascularization in the rat. Invest Ophthalmol Vis Sci. 1992;33(suppl):1280. Abstract.
16. D'Amore PA, Klagsbrun M. Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities. J Cell Biol. 1984;99: 1545-1549.
17. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/Vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995;92:905-909.
18. Khaliq A, Patel B, Jarvis-Evans J, Moriarty P, McLeod D, Boulton M. Oxygen modulates production of bFGF and TGFβ by retinal cells in vitro. Exp Eye Res. 1995;60:415-424.
19. Shima D, Adamis A, Ferrara N, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1995;1:182-193.
20. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circ Res. 1995;77:638-643.
21. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A. 1993;90:4304-4308.
22. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett. 1995;370:203-208.
23. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992;3:211-220.
24. Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun. 1993; 195:1005-1010.
25. Hashimoto E, Ogita T, Nakoaka T, Matsuoka R, Takao A, Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol. 1994;267:H1948-H1954.
26. Millauer B, Wizigmann-Voos S, Schnürch H, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835-846.
27. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A. 1993;90:8915-8919.
28. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
29. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992; 359:843-845.
30. Plouet J, Chollet P, Moro F, Malecaze F. Secretion of VAS/VEGF by retinal pericytes: a paracrine stimulation of endothelial cell proliferation. Invest Ophthalmol Vis Sci. 1993;193:631-638.
31. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A. 1995;92:768-772.
32. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol. 1993;143:1255-1262.
33. Flynn JT. Retinopathy of prematurity. Pediatr Clin North Am. 1987;34:1487-1515.
34. Prost M. Experimental studies on the pathogenesis of retinopathy of prematurity. Br J Ophthalmol. 1988;72:363-367.
35. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes. 1995;44:98-103.
36. Penn JS, Henry MM, Wall PT, Tolman BL. The range of Pa02 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci. 1995;36:2063-2070.
37. Connolly SE, Hjelmeland LM, LaVail MM. Immunohistochemical localization of basic fibroblast growth factor in mature and developing retinas of normal and RCS rats. Curr Eye Res. 1992;11:1005-1017.
38. Roque RS, Caldwell RB. Müller cell changes precede vascularization of the pigment epithelium in the dyslrophic rat retina. Glia. 1990;3:464-475.
39. Adamis AP, Shima DT, Yeo KT, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1993;193:631-638.
40. Korte GE, Repucci V, Henkind P. Retinal pigment epithelium destruction causes choriocapillaris atrophy. Invest Ophthalmol Vis Sci. 1984;25:1135-1145.
41. Burns MS, Hartz MJ. The retinal pigment epithelium induces fenestration of endothelial cells in vivo. Curr Eye Res. 1992;11:863-873.
42. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1995;1:1024-1028.
43. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995; 108:2369-2379.
44. Penn J, Thumm L, Naash M. The rat as an animal model for retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1992;33:1836-1845.
45. Gitay-Goren H, Soker V, Vlodavsky I, Neufeld G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem. 1992;267:6093-6098.
46. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031-26037.
47. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activator and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun. 1991; 181:902-906.
48. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. Lab Invest. 1987;57:673-686.
49. Zweier JL, Kuppusami P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of a free radical injury in postischemic tissues. Proc Natl Acad Sci U S A. 1988;85:4046-4050.
50. Das DK, Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol. 1994;233:601-610.
51. Fukuda S, Al Jada A, Spengler R, et al. Angiogenic factor response of rabbit corneal stroma cells to lipoid hydroperoxide stress in vitro. Invest Ophthalmol Vis Sci. 1996;37(suppl):1014.
52. Gajdusek CM, Carbon S. Injury-induced release of basic flbroblast growth factor from bovine aortic endothelium. J Cell Physiol. 1989;139:570-579.
53. Gao H, Hollyfield JG. Basic flbroblast growth factor (bFGF) immunolocalization in the rodent outer retina demonstrated with an anti-rodent bFGF antibody. J Brain Res. 1992;585:355-360.
54. Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res. 1993;274:163-172.
55. Pepper MS, Ferrara N, Orel L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun. 1992;189: 824-831.
56. Heyman E, Ohlsson A, Girscher P. Retinopathy of prematurity and bilirubin. N Engl J Med. 1989;320:256.
57. Muller DPR. Vitamin E therapy in retinopathy of prematurity. Eye. 1992;6:221-225.
58. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
59. Adamis AP, Miller JW, Bernai M-T, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
60. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994;112: 1476-1482.